Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600116551Phase 4Not yet recruiting
Phase 4, randomised trial of ciprofol (2 arms), sponsored by Zhuzhou Central Hospital. Primary endpoints: Success rate of anesthesia induction and Success rate of inhibiting laryngeal mask reaction. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600116551.